Technical noteManagement of brain AVM procedural hemorrhagic complication by the “security” catheter technique
Introduction
The treatment of intracranial arteriovenous malformation (AVM) is still considered a complex procedure that frequently involves the association of two or even three different techniques [1], such as endovascular embolization, neurosurgery and radiosurgery. In its earlier days, the availability of permanent liquid embolic material for endovascular AVM embolization was restricted to only adhesive embolic agents. The initial experience with these embolic agents revealed low cure rates [2], as they played only a secondary role as adjunctive therapy for surgery or radiosurgery [3], [4]. However, since the introduction of Onyx (ev3, Irvine, CA, USA), a non-adhesive embolic material, higher rates of complete AVM occlusion have been obtained by endovascular embolization as the sole treatment, as shown by several studies [5], [6].
Nevertheless, although Onyx has no adhesive properties, its deposition around the microcatheter can form a high-viscosity plug, imprisoning the microcatheter and making its removal difficult and, in some cases, impossible without vascular tearing. The complication is directly related to the amount of Onyx reflux around the catheter, duration of the injection and tortuosity of arterial access.
Rupture of the arterial pedicle during microcatheter retrieval is a serious and potentially fatal complication. The immediate treatment of this complication is mandatory, requiring prompt endovascular closure of the bleeding point. For this reason, this report describes a simple technique to optimize prompt control of the complication in selected cases where such rupture may be more prone to happen.
Section snippets
Technique
From February 2009 to November 2010, 87 AVM embolization sessions using Onyx were performed at our center. During this period, three brain AVM with compact and small niduses (< 3 cm) were selected for endovascular embolization with Onyx, targeting a curative procedure using the “security catheter” technique.
All selected patients presented with a higher risk of hemorrhagic complication during catheter retrieval due to access tortuosity and distal locations. In two of the AVMs, the arterial supply
Discussion
The use of Onyx as an embolic agent has enabled more significant cure rates for the endovascular treatment of brain AVM. As seen in some studies, the cure rates using endovascular embolization as the sole therapy range from 45% to 60% [5], [6]. However, with the use of more aggressive techniques such as the one recently described by Abud et al. [7], cure rates greater than 90% may be achieved for selected AVMs.
The non-adhesive characteristic of Onyx allows longer injections with gradual
Disclosure of interest
The authors declare that they have no conflicts of interest concerning this article.
References (10)
- et al.
Therapy of brain arteriovenous malformations: multimodality treatment from a balanced standpoint
Neurosurgery
(2006) N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial
AJNR Am J Neuroradiol
(2002)- et al.
Preoperative embolization of brain AVMs with isobutyl-2 cyanoacrylate
AJNR Am J Neuroradiol
(1988) - et al.
Effect of liquid embolic agents on Gamma Knife surgery dosimetry for arteriovenous malformations. Clinical article
J Neurosurg
(2011) - et al.
Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients
AJNR Am J Neuroradiol
(2007)